Tretinoin, also known as retinoic acid, is the active form of vitamin A. Its use in hair loss treatment is less mainstream, but the evidence for its role as a complement to minoxidil is substantive and dates back decades. This article covers what tretinoin does to the scalp, why it is used alongside minoxidil rather than alone, and what the evidence supports.
Tretinoin's Primary Mechanism
Tretinoin (retinoic acid) is the active form of vitamin A. It binds to retinoic acid receptors in the nucleus of skin cells and regulates gene expression related to cell proliferation, differentiation, and extracellular matrix remodeling.
In the context of skin, this means tretinoin:
- ● Accelerates epidermal turnover: old skin cells shed faster
- ● Stimulates collagen synthesis in the dermis
- ● Reduces cornified layer thickness, the outermost layer of skin
For hair loss treatment, the most relevant of these effects are the reduction in the thickness of the stratum corneum and the alteration of skin permeability. By modifying the skin barrier, tretinoin improves the penetration of topically applied drugs — particularly minoxidil.
Tretinoin's main role in hair loss treatment is as a penetration enhancer. It modifies the skin barrier to allow more minoxidil to reach the follicle.
The Evidence for Tretinoin Plus Minoxidil
The combination of tretinoin and minoxidil has been studied since the late 1980s and early 1990s, when researchers began exploring why some patients responded well to minoxidil and others did not.
A landmark 1994 study by Bazzano and colleagues randomized patients with androgenetic alopecia to receive either minoxidil alone, tretinoin alone, or a combination of both. Results showed:
- ● Minoxidil alone: significant improvement in hair growth
- ● Tretinoin alone: modest improvement, less than minoxidil
- ● Combination (minoxidil + tretinoin): significantly greater improvement than minoxidil alone
The combination outperformed minoxidil alone, and not simply by additive effects. Instead, tretinoin actually enhanced the effectiveness of minoxidil by increasing bioavailability.
Tretinoin at low concentrations enhances minoxidil bioavailability in the scalp. The combination produces better hair growth outcomes than minoxidil alone.
Appropriate Concentrations
Tretinoin is available in concentrations ranging from 0.01% to 0.1%. The concentrations studied in hair loss research are at the lower end of the range.
- 0.01%: The concentration most often used in combination hair loss formulas. At this level, irritation is minimal for most people, and efficacy enhancement is meaningful.
- 0.025%: Used in some formulations. Slightly more potent and potentially more irritating.
- 0.05–0.1%: Concentrations typically used for acne and anti-aging. Too high for regular scalp application in most patients. Causes significant irritation at these concentrations on the scalp.
When weighing the potential for irritation and efficacy, 0.01% likely represents the best concentration for combining tretinoin and minoxidil.
0.01% tretinoin is the standard concentration in compounded hair loss formulas. Higher concentrations are generally too irritating for scalp application and likely unnecessary.
Side Effects and Considerations
At the low concentrations used in hair loss treatment, tretinoin is generally well tolerated.
Potential side effects include:
- Scalp irritation: Redness, itching, or peeling, particularly during initial use. This typically diminishes after the first two to four weeks as the scalp adjusts.
- Photosensitivity: Retinoids increase skin sensitivity to UV radiation. Scalp sun protection is important with regular use, i.e. a hat or scalp sunscreen if sun exposure is anticipated.
- Dryness: Tretinoin accelerates cell turnover and can cause temporary dryness or flakiness. This generally resolves within the first month of use.
For female hair loss patients, tretinoin is contraindicated in pregnancy and for women who may become pregnant.
At 0.01%, tretinoin is well tolerated by most patients with an adjustment period. Photosensitivity is a real consideration. For females, tretinoin should be avoided if trying to conceive.
How Tretinoin Fits in a Protocol
Tretinoin is not a standalone hair loss treatment. In clinical use, it appears as a component of compounded topical formulas that combine it with minoxidil.
The rationale for including tretinoin in a compounded formula is straightforward: it is inexpensive, causes minimal additional irritation at 0.01%, and is supported by evidence of improved minoxidil efficacy. For patients on topical minoxidil, the incremental benefit of adding tretinoin to the regimen is well supported.
Tretinoin is most useful as part of a compounded topical formula rather than as a standalone product. Its role is to optimize minoxidil delivery.
The Bottom Line
Tretinoin improves minoxidil bioavailability by modifying sulfotransferase enzyme activity, producing significantly better hair growth outcomes compared to minoxidil alone. At 0.01%, it is well tolerated by most patients. Tretinoin is most useful as a component of a compounded topical formula containing minoxidil, rather than as a standalone treatment. Sun protection of the scalp is an important consideration with regular use.